<li>conduct research into the causes, prevention, diagnosis and methods of cancer treatment;</li>
The research will be carried out in a new $30 million Centre for Molecular Pathology (CMP)&lt;<a>http://www.icr.ac.uk/support_us/appeals/mol_pathology/index.shtml</a>&gt; and will build on their existing expertise in breast, prostate and paediatric cancers, while providing opportunities for new developments in other cancers such as gastrointestinal, renal, gynaecological, melanoma, head &amp; neck cancers and sarcomas.
